This study demonstrates that New bitongling ameliorates joint damage in collagen-induced arthritis mice by suppressing microtubule-associated protein tau expression, restoring mitochondrial function, and modulating synovial inflammation. These findings provide preclinical evidence supporting further investigation of New bitongling as a novel therapeutic agent for rheumatoid arthritis.